Koers PetVivo Holdings, Inc. Other OTC
Aandelen
Medische apparatuur, benodigdheden & distributie
Omzet 2024 * | 2,66 mln. 2,49 mln. | Omzet 2025 * | 8,9 mln. 8,33 mln. | Marktkapitalisatie | 8,94 mln. 8,36 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -12 mln. -11,23 mln. | Nettowinst (verlies) 2025 * | -9 mln. -8,42 mln. | EV/omzet 2024 * | 3,36 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 1 x |
K/w-verhouding 2024 * |
-0,46
x | K/w-verhouding 2025 * |
-0,71
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 55,94% |
Recentste transcriptie over PetVivo Holdings, Inc.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Dolan
FOU | Founder | 58 | 31-03-09 |
John Lai
FOU | Founder | 61 | 31-03-09 |
Garry Lowenthal
DFI | Director of Finance/CFO | 64 | 08/03 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 65 | 27-07-22 | |
John Lai
FOU | Founder | 61 | 31-03-09 |
John Breithaupt
BRD | Director/Board Member | 63 | 14-04-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-4,36% | 184 mld. | |
-3,11% | 103 mld. | |
-4,84% | 67,59 mld. | |
+15,70% | 46,93 mld. | |
-9,14% | 43,87 mld. | |
+8,28% | 41,2 mld. | |
+17,38% | 30,47 mld. | |
+13,59% | 24,16 mld. | |
-7,40% | 23,57 mld. |